NDC Package 72238-001-01 Vamousse Lice Treatment

Pediculicide Aerosol, Foam Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72238-001-01
Package Description:
1 BOTTLE, WITH APPLICATOR in 1 BOX / 177 mL in 1 BOTTLE, WITH APPLICATOR
Product Code:
Proprietary Name:
Vamousse Lice Treatment
Non-Proprietary Name:
Pediculicide
Substance Name:
Sodium Chloride
Usage Information:
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.
11-Digit NDC Billing Format:
72238000101
Product Type:
Human Otc Drug
Labeler Name:
Alliance Pharma Inc.
Dosage Form:
Aerosol, Foam - A dosage form containing one or more active ingredients, surfactants, aqueous or nonaqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.
Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Active Ingredient(s):
    Sample Package:
    No
    Marketing Category:
    UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
    Start Marketing Date:
    10-01-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72238-001-01?

    The NDC Packaged Code 72238-001-01 is assigned to a package of 1 bottle, with applicator in 1 box / 177 ml in 1 bottle, with applicator of Vamousse Lice Treatment, a human over the counter drug labeled by Alliance Pharma Inc.. The product's dosage form is aerosol, foam and is administered via topical form.

    Is NDC 72238-001 included in the NDC Directory?

    Yes, Vamousse Lice Treatment with product code 72238-001 is active and included in the NDC Directory. The product was first marketed by Alliance Pharma Inc. on October 01, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 72238-001-01?

    The 11-digit format is 72238000101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-272238-001-015-4-272238-0001-01